# Establishment of a Strategy for Preventing Graft-versus-host Disease After Allogeneic Hematopoietic Cell Transplantation by Exploring Immune Mechanisms of Regulatory and Effector T Cells

> **NCT07150468** · — · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 146 (actual)

## Conditions studied

- Acute Leukemia, Myelodysplastic Syndrome, Myeloproliferative Neoplasms, Lymphoma, Multiple Myeloma

## Interventions

- **OTHER:** sampling blood

## Key facts

- **NCT ID:** NCT07150468
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-13
- **Primary completion:** 2025-08-13
- **Final completion:** 2025-08-20
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2025-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07150468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07150468, "Establishment of a Strategy for Preventing Graft-versus-host Disease After Allogeneic Hematopoietic Cell Transplantation by Exploring Immune Mechanisms of Regulatory and Effector T Cells". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07150468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*